CV Sciences (CVSI) Net Margin (2013 - 2026)
CV Sciences (CVSI) posted Net Margin of 20.13% for Q1 2026, down 513.38% sequentially from 4.87% in Q4 2025, and down 1710.0% YoY from 1.25% in Q1 2025.
CV Sciences (CVSI) Net Margin (2013 - 2026) Analysis & Trends
CV Sciences has reported Net Margin for 14 years, with the latest figure at 20.13% in Q1 2026.
- Quarterly Net Margin fell 1710.0% year-over-year to 20.13% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.41% (up 213.0% YoY) and the FY2025 annual result came in at 4.29%, up 1096.0% from the prior year.
- Net Margin declined to 20.13% in Q1 2026 per CVSI's latest filing, from 4.87% in the prior quarter.
- Over five years, Net Margin peaked at 137.56% in Q1 2023 and troughed at 86.35% in Q2 2022.
- A 5-year average of 14.2% and a median of 14.77% in 2024 frame the typical range for Net Margin.
- The sharpest annual moves came in 2023 and 2024: Net Margin soared 18512 bps in 2023, then sank 15325 bps in 2024.
- Over 5 years, Net Margin stood at 59.78% in 2022, then jumped by 62 bps to 22.86% in 2023, then surged by 48 bps to 11.97% in 2024, then jumped by 141 bps to 4.87% in 2025, then sank by 513 bps to 20.13% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 20.13%, 4.87%, and 11.73% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | -25.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.96% |
| Mar 31, 2026 | -20.13% |
| Dec 31, 2025 | 4.87% |
| Sep 30, 2025 | -11.73% |
| Jun 30, 2025 | -7.21% |
| Mar 31, 2025 | -3.02% |
| Dec 31, 2024 | -11.97% |
| Sep 30, 2024 | -11.80% |
| Jun 30, 2024 | -14.77% |
| Mar 31, 2024 | -15.69% |
| Dec 31, 2023 | -22.86% |
| Sep 30, 2023 | -10.93% |
| Jun 30, 2023 | -32.48% |
| Mar 31, 2023 | 137.56% |
| Dec 31, 2022 | -59.78% |
| Sep 30, 2022 | -27.49% |
| Jun 30, 2022 | -86.35% |
| Mar 31, 2022 | -47.56% |
| Dec 31, 2021 | -178.25% |
| Sep 30, 2021 | -0.78% |